Data / Form D filings / Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc.: Form D filings
Nucleus Radiopharma, Inc., a health care company in Palo Alto, CA, filed 2 Form D notices with the SEC in 2024. The latest, on April 11, 2024, reports $66.1 million sold of a $66.1 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 514 HIGH STREET, Palo Alto, CA, 94301
- Phone
- (980) 483-3788
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2004065
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 11, 2024 | New notice | $66,099,956 | $66,099,956 | 12 | Sep 15, 2023 | sec.gov | |
| Apr 11, 2024 | New notice | $6,000,000 | $6,000,000 | 3 | Oct 4, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tyrell Rivers | Director | |
| Mary Kate Wold | Director | |
| Michael Rossi | Director | |
| Norman Sharpless | Director | |
| Chris McDonald | Director | |
| Manu Nair | Director | |
| Justin Butler | Director | |
| Charles Conroy | Executive Officer, Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Apr 8, 2024 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Nucleus Radiopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.